Qrono, Inc. — Department of Health and Human Services SBIR Phase I: 116
Qrono, Inc. — SBIR Phase I award from Department of Health and Human Services.
- Amount
- $599,945
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase I
- Topic
- 116
- Solicitation
- PHS-2023-1
- NAICS
- —
- Place of performance
- PA
- Period
- —
Description
Celiac disease (CD) is a human chronic autoimmune disorder of the small intestine driven by adaptive immune responses to gluten peptides in wheat, barley, and rye. The contractor is targeting dendritic cells and macrophages to discovery new tolerogenic adjuvants which when paired with gluten antigens, may enable the first clinically viable immunotherapy for CD patients.